U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C11H15ClN2O2
Molecular Weight 242.702
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of IPROCLOZIDE

SMILES

CC(C)NNC(=O)COC1=CC=C(Cl)C=C1

InChI

InChIKey=GGECDTUJZOXAAR-UHFFFAOYSA-N
InChI=1S/C11H15ClN2O2/c1-8(2)13-14-11(15)7-16-10-5-3-9(12)4-6-10/h3-6,8,13H,7H2,1-2H3,(H,14,15)

HIDE SMILES / InChI
Molecular Formula C11H15ClN2O2
Molecular Weight 242.702
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Iproclozide [1-(p-chlorophenoxyacetyl)-2-isopropylhydrazine] is a non-selective monoamine oxidase inhibitor. It has been used in the treatment of depressive states. Iproclozide was studied in the treatment of hypertension and angina pectoris. It may induce fatal hepatitis.

Approval Year

Unknown
149,124

Targets

Primary TargetPharmacologyConditionPotency
Monoamine oxidase
32
Inhibitor
8,504

PubMed

Substance Class Chemical
Record UNII
1II9D6CB3J
Record Status Validated (UNII)
Record Version
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966